Insider Trading: McKesson Corp (MCK)
MCK on New York Consolidated
118.02USD
20 May 2013
118.02USD
20 May 2013
Price Change (% chg)
$1.13 (+0.97%)
$1.13 (+0.97%)
Prev Close
$116.89
$116.89
Open
$116.63
$116.63
Day's High
$118.82
$118.82
Day's Low
$116.63
$116.63
Volume
1,263,728
1,263,728
Avg. Vol
1,381,414
1,381,414
52-wk High
$118.82
$118.82
52-wk Low
$84.65
$84.65
FIGUEREDO JORGE L
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 17 Jan 2013 | Sell | 2,500 | $103.22 | 268 |
| 17 Jan 2013 | Buy | 2,500 | $67.81 | 268 |
| 16 Jan 2013 | Sell | 10,000 | $102.20 | 268 |
| 16 Jan 2013 | Buy | 10,000 | $67.81 | 268 |
| 15 Jan 2013 | Sell | 10,000 | $101.78 | 268 |
| 15 Jan 2013 | Buy | 10,000 | $67.81 | 268 |
| 14 Jan 2013 | Buy | 10,000 | $67.81 | 268 |
| 14 Jan 2013 | Sell | 10,000 | $101.34 | 268 |
| 4 Dec 2012 | Sell | 10,000 | $93.33 | 268 |
| 4 Dec 2012 | Buy | 10,000 | $57.89 | 268 |
| 1 Jul 2012 | Sell | 30,000 | $95.00 | 267 |
| 1 Jul 2012 | Buy | 30,000 | $57.89 | 267 |
| 28 May 2012 | Sell | 22,500 | $87.64 | 267 |
| 28 May 2012 | Buy | 22,500 | $40.46 | 267 |
| 20 May 2012 | Sell | 12,557 | $87.02 | 267 |
| 19 May 2012 | Sell | 10,048 | $87.45 | 267 |
| 19 May 2012 | Buy | 22,605 | $0.00 | 267 |
| 8 Mar 2012 | Sell | 2,500 | $85.67 | 266 |
| 8 Mar 2012 | Buy | 2,500 | $40.46 | 266 |
| 7 Mar 2012 | Sell | 10,000 | $85.00 | 266 |
| 7 Mar 2012 | Buy | 10,000 | $40.46 | 266 |
| 27 Oct 2011 | Sell | 10,000 | $85.00 | 266 |
| 27 Oct 2011 | Buy | 10,000 | $40.46 | 266 |
| 22 May 2011 | Sell | 5,453 | $83.76 | 264 |
| 19 May 2011 | Buy | 10,000 | $0.00 | 264 |
Institutional Holders
| % Shares Owned: | 89.44% |
| # of Holders: | 905 |
| Total Shares Held: | 202,691,951 |
| 3 Mo. Net Change: | 290,144 |
| # New Positions: | 78 |
| # Closed Positions: | 62 |
| # Increased Positions: | 353 |
| # Reduced Positions: | 401 |
| # Net Buyers: | -48 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
John Hammergren |
53 | 2002 | Chairman of the Board, President, Chief Executive Officer |
Jeffrey Campbell |
52 | 2004 | Chief Financial Officer, Executive Vice President |
Randall Spratt |
60 | 2009 | Chief Information Officer, Chief Technology Officer, Executive Vice President |
Laureen Seeger |
51 | 2010 | Chief Compliance Officer, Executive Vice President, General Counsel |
Jorge Figueredo |
51 | 2008 | Executive Vice President - Human Resources |
Patrick Blake |
48 | 2009 | Executive Vice President, Group President |
Paul Julian |
56 | 2004 | Executive Vice President, Group President |
Brian Tyler |
45 | 2012 | Executive Vice President - Corporate Strategy and Business Development; President - U.S. Pharmaceutical Business |
Andy Bryant |
62 | 2008 | Independent Director |
Wayne Budd |
70 | 2003 | Independent Director |
Alton Irby |
71 | 1999 | Independent Director |
M. Christine Jacobs |
61 | 1999 | Independent Director |
Marie Knowles |
65 | 2002 | Independent Director |
David Lawrence |
72 | 2004 | Independent Director |
Edward Mueller |
65 | 2008 | Independent Director |
Jane Shaw |
73 | 1992 | Independent Director |
Erin Lampert |
Vice President - Investor Relations |

